Logo

Crossref


1. Liver Dysfunction After Use of Nathanson Retractor During Laparoscopic Gastrectomy for Gastric Cancer

- Serdar Culcu

- Selim Tamam

- Cem Azili

- Siyar Ersoz

- Baris Morkavuk

- Ali Ekrem Unal

- Salim Demirci

2. Evaluation of oral silymarin formulation efficacy in prevention of doxorubicin induced hepatotoxicity in patients with non-metastatic breast cancer

- Ashkan Fatemi Shandiz

- Gholamreza Karimi

- Mahdiyeh Dayyani

- Sare Hosseini

- Sepideh Elyasi

3. The Evidence Surrounding Non-Alcoholic Fatty Liver Disease in Individuals with Cancer: A Systematic Literature Review

- Elena S. George

- Surbhi Sood

- Nicole Kiss

- Robin M. Daly

- Amanda J. Nicoll

- Stuart K. Roberts

- Brenton J. Baguley

4. Oral silymarin formulation efficacy in management of AC-T protocol induced hepatotoxicity in breast cancer patients: A randomized, triple blind, placebo-controlled clinical trial

- Ghazal Sadat Askarpour Moezian

- Seyed Alireza Javadinia

- Soodabeh Shahid Sales

- Azar Fanipakdel

- Sepideh Elyasi

- Gholamreza Karimi

5. Cardiotoxicity and pharmacogenetics of doxorubicin in black Zimbabwean breast cancer patients

- Vincent Aketch Nyangwara

- Tinashe Mazhindu

- Zedias Chikwambi

- Collen Masimirembwa

- Thomas B. Campbell

- Margaret Borok

- Ntokozo Ndlovu

6. Animal models of chemotherapy-induced cognitive decline in preclinical drug development

- Jeena John

- Manas Kinra

- Jayesh Mudgal

- G. L. Viswanatha

- K. Nandakumar